What To Buy After You Sell The Russell 2000 [Seeking Alpha]
Acrivon Therapeutics, Inc. (ACRV)
Company Research
Source: Seeking Alpha
The S&P 600 and the CRSP Small Cap Index do not suffer from the same issues as the Russell 2000, and they have performed better than it. IJR, VB, and AVUV are all good alternatives to IWM, VTWO, and VRTIX. There is a strong case to be made for having a position in small cap stocks at this time. Reasons include: Anticipated Fed easing may lift small caps more than large caps Mean reversion - small caps have underperformed large caps by historic amounts over the past five years A potential slow down or reversal of the rally in tech which has disproportionally benefitted large cap indices such as the S&P 500. Despite this, I recently wrote an article on Seeking Alpha recommending that investors sell the Russell 2000 and ETFs such as IWM VRTIX , and VTWO that track it, due to the negative alpha (lower returns and higher risk) that it suffers from. This is largely due to seasonal factors related to Russell 2000's annual re-balancing of stocks on the fourth Friday of June, and
Show less
Read more
Impact Snapshot
Event Time:
ACRV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACRV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACRV alerts
High impacting Acrivon Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
ACRV
News
- Acrivon Therapeutics, Inc. (NASDAQ: ACRV) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.MarketBeat
- Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its price target raised by analysts at BMO Capital Markets from $18.00 to $25.00. They now have an "outperform" rating on the stock.MarketBeat
- Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its price target raised by analysts at JMP Securities from $14.00 to $17.00. They now have a "market outperform" rating on the stock.MarketBeat
- Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its price target raised by analysts at Piper Sandler from $26.00 to $30.00. They now have an "overweight" rating on the stock.MarketBeat
- Acrivon Therapeutics, Inc. (NASDAQ: ACRV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.MarketBeat
ACRV
Earnings
- 8/11/23 - Beat
ACRV
Sec Filings
- 4/30/24 - Form EFFECT
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- ACRV's page on the SEC website